UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in LLY — ELI LILLY & Co
CIK 861177
NEW YORK, NY
Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,504,632,749
-$480,067,858 QoQ
Shares Held
7,072,021
+8.8% QoQ
Ownership
0.751%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 48.92462847607494.ToString("F0")%
Shared 0.ToString("F0")%
None 51.075371523925064.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $23,080,171,805 across 16 Drug Manufacturers - General names. LLY ranks #1 (28.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
7,072,021 | $6,504,632,749 | |
| 2 | JNJ |
Johnson & Johnson
|
19,628,113 | $4,797,895,938 | |
| 3 | ABBV |
AbbVie Inc.
|
14,161,606 | $3,080,007,683 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,414,819 | $2,455,698,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,199,103 | $1,839,558,979 | |
| 6 | AMGN |
Amgen Inc
|
4,784,982 | $1,683,595,911 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
22,719,320 | $1,377,926,752 | |
| 8 | PFE |
Pfizer Inc
|
34,522,932 | $969,403,925 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,504,632,749 | 7,072,021 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,984,700,607 | 6,499,330 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $4,908,346,191 | 6,432,957 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $6,136,055,574 | 7,871,481 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,597,680,174 | 6,777,591 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $5,469,527,360 | 7,084,880 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,417,969,605 | 6,115,504 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,394,039,457 | 5,957,763 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,594,062,387 | 4,619,855 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,622,166,517 | 4,498,330 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,348,752,389 | 4,372,782 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,166,974,607 | 4,620,612 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,586,810,564 | 4,620,612 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,565,836,168 | 4,280,112 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,288,730,173 | 3,985,558 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,357,565,595 | 4,187,045 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,261,355,031 | 4,404,634 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,206,769,265 | 4,368,870 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,041,242,528 | 4,506,568 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,069,405,971 | 4,659,315 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $818,997,015 | 4,383,883 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $720,411,066 | 4,266,827 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $655,452,240 | 4,428,133 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $713,277,706 | 4,344,486 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $624,557,941 | 4,502,292 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||